化合物 Ki23057 T69162
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
TargetMol | 生产商 | 美国 | 现货 |
性能特点
生化试剂,可用于动物细胞实验
规格 | CAS号 | 价格 | 操作 |
---|---|---|---|
50 mg | 516523-31-2 | ¥13,800.00 | 询底价 |
100 mg | 516523-31-2 | ¥17,500.00 | 询底价 |
25 mg | 516523-31-2 | ¥10,600.00 | 询底价 |
Product Introduction
Bioactivity
英文名: Ki23057
描述: Ki23057 is a a FGFR2 inhibitor, which enhances the chemosensitivity of drug-resistant gastric cancer cell lines when used in combination with chemotherapeutic drugs. Ki23057 might be therapeutically promising for treating drug-resistant gastric cancer cells, especially when used in combination with SN38, PTX, or VP16. The apoptosis process might be the main mechanism underlying the synergistic effect of these combinations. The ERCC1 and p53 genes may play an integral role in the synergism between Ki23057 and chemotherapeutic agents in drug-resistant cell lines. (source: Cancer Lett. 2011 Aug 1;307(1):47-52).
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
关键字: Ki 23057. | Ki-23057 | Ki23057
化合物 Ki23057 T69162信息由TargetMol中国为您提供,如您想了解更多关于化合物 Ki23057 T69162报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途